Hao-Yuan Chuang, Director, Chief Financial Officer, on September 04, 2026, sold 67,395 shares in Belite Bio (BLTE) for $12,803,528. Following the Form 4 filing with the SEC, Chuang has control over a total of 26,038 American depositary shares of the company, with 26,038 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1889109/000119312526386790/xslF345X05/ownership.xml